Projects per year
Personal profile
Biography
Anton Peleg is Professor of Infectious Diseases and Microbiology and Director of the Department of Infectious Diseases at the Alfred Hospital and Monash University. He is also a research group leader in the Department of Microbiology, Monash University. His research spans clinical to basic research, with a focus on hospital-acquired infections, antimicrobial resistance, infections in immunocompromised hosts and understanding mechanisms of disease caused by hospital pathogens. He has a particular clinical interest in complex infections in highly vulnerable patient groups, including patients with cystic fibrosis, lung and stem cell transplant recipients, and infections in patients with burns or in intensive care.
Anton is a founding member of the Monash Centre to Impact AMR, launched early 2020.
Clinical activities
Infectious Diseases Physician, Alfred Hospital, Melbourne VIC
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Education/Academic qualification
Bachelor of Medicine, Bachelor of Surgery, MONASH UNIVERSITY
Award Date: 19 Feb 2027
Microbiology and Infectious Diseases, Doctor of Philosophy, University of Queensland
2010 → …
Master of Public Health, Harvard University
2009 → …
External positions
Director Infectious Diseases Clinic, Alfred Hospital
Head of Travel Medicine Clinic, Alfred Hospital
Head, Victorian NPEP Service, Alfred Hospital
Executive, Monash Partners
Research area keywords
- antibiotic prescribing
- antibiotic resistance
- antimicrobial stewardship
- qualitative research
- resi
- bacteria
- candida
- epidemiology
- hematopoietic stem cell transplantation
- infection
- microbial drug
- diabetes
- immunity
- glycaemic control
- hospital-acquired infections
- antimicrobial resistance
- infections in immunocompromised hosts
Collaborations and top research areas from the last five years
-
PHASEK: Phage-Antimicrobial combination Strategies for management of multidrug-resistant E. coli and K. pneumoniae
Abbott, I. (Primary Chief Investigator (PCI)), Peleg, A. (Chief Investigator (CI)), Landersdorfer, C. (Chief Investigator (CI)), Starkey, M. (Chief Investigator (CI)) & Gordillo Altamirano, F. (Chief Investigator (CI))
1/04/25 → 30/03/28
Project: Research
-
Optimised prosthetic heart valve surfaces to prevent infective endocarditis.
Rogers, B. (Primary Chief Investigator (PCI)), Robson, C. (Chief Investigator (CI)), Qu, Y. (Chief Investigator (CI)), Peleg, A. (Chief Investigator (CI)), Bennetts, J. (Chief Investigator (CI)), Nicholls, S. (Chief Investigator (CI)) & Forsythe, J. (Chief Investigator (CI))
1/02/25 → 31/01/27
Project: Research
-
Optimised Infection Prevention and Control Study in Residential Aged Care Homes (OPTICS)
Peleg, A. (Primary Chief Investigator (PCI)), Stewardson, A. (Chief Investigator (CI)), Stuart, R. (Chief Investigator (CI)), Peel, T. (Chief Investigator (CI)), Jokanovic, N. (Chief Investigator (CI)), Bucknall, T. (Chief Investigator (CI)), Ayton, D. (Chief Investigator (CI)), Haines, T. (Chief Investigator (CI)) & Rawson, H. (Chief Investigator (CI))
1/02/25 → 31/01/29
Project: Research
-
Harnessing type VI secretion system lysins for fighting bacterial superbugs
Boyce, J. (Primary Chief Investigator (PCI)), Harper, M. (Chief Investigator (CI)), Roper, D. (Chief Investigator (CI)), Landersdorfer, C. (Associate Investigator (AI)), Peleg, A. (Associate Investigator (AI)) & Vollmer, W. (Associate Investigator (AI))
1/01/25 → 31/12/27
Project: Research
-
Overcoming resistance emergence to recent antibiotics by a multi-omics informed quantitative and systems pharmacology approach
Landersdorfer, C. (Primary Chief Investigator (PCI)), Oliver, A. (Chief Investigator (CI)), Harper, M. (Chief Investigator (CI)), Boyce, J. (Associate Investigator (AI)) & Peleg, A. (Associate Investigator (AI))
1/01/25 → 31/12/28
Project: Research
-
Accurate quantitation of antibiotic penetration through staphylococcal biofilms
Bin, L. (Leading Author), McGiffin, D., Nguyen, T., Wang, L., Sun, Y., Ye, L., Han, M., Sheng, C., Lee, T.-H., Aguilar, M.-I., Peleg, A. Y. & Qu, Y. (Leading Author), Dec 2025, In: Biofilm. 10, 100316, 9 p., 100316.Research output: Contribution to journal › Article › Research › peer-review
Open Access -
Biological Merits and Antibiofilm Mechanisms of Action of a Specially Designed Double-Shelled Microparticle
Sheng, C., Zhou, C., Guo, M., McGiffin, D. C., Kaye, D. M., Truong, V. X., Qian, C., Kostoulias, X., Peleg, A. Y., Forsythe, J. S. (Leading Author), Scott, T. F. (Leading Author) & Qu, Y. (Leading Author), 26 Aug 2025, In: ACS Omega. 10, 35, p. 40271-40281 11 p.Research output: Contribution to journal › Article › Research › peer-review
Open Access -
Ceftolozane/tazobactam disrupts Pseudomonas aeruginosa biofilms under static and dynamic conditions
Kostoulias, X., Fu, Y., Morris, F. C., Yu, C., Qu, Y., Chang, C. C., Blakeway, L., Landersdorfer, C. B., Abbott, I. J., Wang, L., Wisniewski, J., Yu, Y., Li, J. & Peleg, A. Y., Feb 2025, In: Journal of Antimicrobial Chemotherapy. 80, 2, p. 372-380 9 p.Research output: Contribution to journal › Article › Research › peer-review
Open Access1 Citation (Scopus) -
Changes in isolation guidelines for CPE patients results in only mild reduction in required hospital beds
Lydeamore, M. J. (Leading Author), Wu, D., Donker, T., Gorrie, C., Higgs, C. K., Easton, M., Hennessy, D., Geard, N., Howden, B. P., Cooper, B. S., Wilson, A., Peleg, A. Y. & Stewardson, A. J. (Leading Author), May 2025, In: Infection, Disease and Health. 30, 2, p. 128-131 4 p.Research output: Contribution to journal › Article › Research › peer-review
Open AccessFile -
Genomic diversity of clinically relevant bacterial pathogens from an acute care hospital in Suva, Fiji
Hawkey, J. (Leading Author), Loftus, M. J., Prasad, A., Vakatawa, T., Prasad, V., Tudravu, L., Pragastis, K., Wisniewski, J., Harshegyi-Hand, T., Blakeway, L., Stewardson, A. J., Jenney, A. W. & Peleg, A. Y. (Leading Author), 1 Jun 2025, In: JAC-Antimicrobial Resistance. 7, 3, 10 p., dlaf058.Research output: Contribution to journal › Article › Research › peer-review
Open Access
Prizes
-
BDI Clinical Engagement and Research Translation Award
Qu, Y. (Recipient) & Peleg, A. (Recipient), 1 Dec 2021
Prize: Prize (including medals and awards)
-
MONASH UNIVERSITY (Organisational unit)
Payne, J. (Inventor), Cryle, M. (Inventor), Peleg, A. (Inventor) & Tailhades, J. (Inventor)
23 Apr 2020Activity: Industry, Government and Philanthropy Engagement and Partnerships › Patents › Patent (Provisional)
-
Monash Antimicrobial Resistance Group (Event)
Lithgow, T. (Chair/Co-Chair), Cryle, M. (Member), Tuck, K. (Member), Traven, A. (Member), Naderer, T. (Member), Rood, J. (Member), Lyras, D. (Member), Peleg, A. (Member), Aguilar, M. (Member), Coulibaly, F. (Member), McGowan, S. (Member), Okeeffe, M. A. (Member), Belousoff, M. (Member) & Heraud, P. (Member)
1 Mar 2017 → 1 Jan 2019Activity: Industry, Government and Philanthropy Engagement and Partnerships › Membership of industry collaboration/ network
Press/Media
-
Scientists discover new phage therapy combination to combat antibiotic-resistance
Barr, J., Gordillo Altamirano, F. & Peleg, A.
9/05/22
1 item of Media coverage
Press/Media: Research
-
Recognising outstanding contributions and reflecting on 2021
14/12/21
1 Media contribution
Press/Media: Other
-
Faculty of Opinions recommendation
Payne, J., Cryle, M., Tailhades, J., Fulcher, A., Ellett, F., Irima, D., Kostoulias, X., Leung, R., Louch, S., Tran, A., Weber, S., Schittenhelm, R., Lieschke, G., Qin, C. H., Peleg, A. & Fu, T.
3/12/21
1 item of Media coverage
Press/Media: Article/Feature